Inflammatory markers to predict stroke recovery
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at certain blood test ratios (like monocyte-to-albumin and neutrophil-to-albumin) to see if they can predict how severe a stroke is and how well a person will recover. It's for people having their first-ever ischemic stroke and who have not had certain treatments or other medical conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had an acute ischemic stroke (a stroke caused by a clot) confirmed by a CT or MRI scan.
- You were admitted to the hospital within 48 hours of your stroke symptoms starting.
- You have not had a prior stroke or received clot-busting medicine or a clot removal procedure.
- You do not have any active infections, autoimmune or inflammatory diseases, severe liver or kidney disease, or blood disorders affecting white blood cells.
- You are not taking immune-suppressing drugs, steroids, or have any cancer (excluding fully removed skin cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced analysis of your blood and stool samples to better predict how you will recover from a stroke and whether it might happen again. It aims to help doctors personalize your care after a stroke.
This study looks at blood tests to find signs of immune activity after a suspected stroke. It may help doctors diagnose stroke faster and better understand what is happening in the body soon after symptoms start.
This study looks at inflammatory cells in the blood and the blood clot removed from the brain during a stroke emergency. The goal is to better understand the role of inflammation in stroke, which could lead to improved treatments.
This study looks at whether certain blood tests taken after a mechanical thrombectomy (a procedure to remove a blood clot from the brain) can help predict how well a patient will recover from a stroke. The goal is to find early signs that might guide future treatment and improve outcomes.
This study looks at inflammation signals in the body and in brain MRI scans after treatment to reopen a blocked brain artery. It may help researchers understand who benefits most from different “reperfusion” treatments like clot-busting medicine or procedures.
This trial looks at blood “inflammation-related” biomarkers to understand what happens early after certain sudden brain events. It may help doctors predict outcomes and tailor treatment for people like those with stroke types that sometimes need a clot-removal procedure.
Hear when a new Acute Ischemic Stroke (AIS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.